In the era of rapid mRNA-based vaccines: why is there no effective hepatitis C virus vaccine yet?

Hepatitis C virus (HCV) is responsible for no less than 71 million people chronically infected and is one of the most frequent indications for liver transplantation worldwide. Despite direct-acting antiviral therapies fuel optimism in controlling HCV infections, there are several obstacles regarding...

Full description

Bibliographic Details

Main Author:	Echeverría Chagas, Natalia (author)
Other Authors:	Comas Almada, Victoria (author), Aldunate Caramori, Fabián (author), Perbolianachis Duarte, Paula (author), Moreno Karlen, María del Pilar (author), Cristina, Juan (author)
Format:	article
Language:	English
Published:	2021
Subjects:	Hepatitis C virus Vaccine candidates Nucleic acid-based vaccines Recombinant vector-based vaccines Challenges COVID-19
Online Access:	https://hdl.handle.net/20.500.12008/41395
Tags:	Add Tag No Tags, Be the first to tag this record!